[1]
Fadakar, P., Akbari, A., Ghassemi, F., Mobini, G.R., Mohebi, M., Bolhassani, M., Abed Khojasteh, H. and Heidari, M. 2016. Evaluation of SD-208, a TGF-β-RI Kinase Inhibitor, as an Anticancer Agent in Retinoblastoma. Acta Medica Iranica. 54, 6 (Jun. 2016), 352-358.